A Medical Device Daily

U.S. Genomics (Woburn, Massachusetts) and Lahey Clinic (Burlington, Massachusetts) reported the signing of a discovery agreement to study the role microRNAs play in the development of urologic cancers.

The objective of the collaboration is to develop more accurate prognoses for bladder and prostate cancer patients. The collaboration combines U.S. Genomics’ patented Trilogy 2020 platform and Direct miRNA assay with Lahey Clinic’s expertise in the analysis of tumor progression and experience in disease management.

In other agreement news:

The Massachusetts eHealth Collaborative (MAeHC; Cambridge, Massachusetts) has selected Wellogic (also Cambridge) as its technology vendor to build a health information exchange connecting three hospitals and more than 100 physician practices, as well as reference labs, imaging centers, pharmacies, and other healthcare service providers and trading partners. Financial terms were not disclosed.

Development of this exchange utility marks the second phase of MAeHC’s charter to bring together the state’s major healthcare stakeholders for the purpose of establishing an interoperable electronic health record system.

The MAeHC was formed in 2004 with a $50 million commitment from Blue Cross Blue Shield of Massachusetts.